Liver transplantation exceeding UCSF criteria: Case report of a late recurrence treated by surgery and review of the literature

European Surgical Research

Volumn 44, Issue 1, 2010, Pages 52-55

  Piardi, T ^a   Audet, M ^a   Odeh, M ^a   Panaro, F ^a   Cag, M ^a   El Ahmar, J ^a   Baiocchi, G L ^c   Schneider, A ^b   Wolf, P ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Recurrence

Indexed keywords

CYCLOSPORIN; DOXORUBICIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; BONE METASTASIS; CANCER RECURRENCE; CANCER STAGING; CASE REPORT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LAMINECTOMY; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECURRENCE RISK; SPINE METASTASIS;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 71249109353     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000264635     Document Type: Article

References (22)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
2. Roberts MS, Angus DC, Bryce CL, et al: Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004; 10: 886-897.
3. Bruix J, Llovet JM: Prognosis and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 1019-1021.
4. Busuttil RW, Farmer DG, Yersiz H, et al: Analysis of long-term outcomes of 3,200 liver transplantations over two decades: a single- center experience. Ann Surg. 2005; 241: 905-916.
5. Tan KC, Rela M, Ryder SD, et al: Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg 1995; 82: 253-256.
6. Ringe B, Pichlmayr R, Wittekind C, Tusch G: Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15: 270-285.
7. Yao FY, Ferrell L, Bass NM, et al: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403.
8. Duffy JP, Vardanian A, Benjamin E, et al: Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22- year experience with 467 patients at UCLA. Ann Surg 2007; 246: 502-509.
9. Roayaie S, Schwartz JD, Sung MW, et al: Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis, Liver Transpl 2004; 10: 534.
10. Regalia E, Fassati LR, Valente U, et al: pattern and management of recurrent hepatocellular carcinoma after liver transplantation. J Hepat Bil Pancr Surg 1998; 5: 29.
11. Merli M, Gentili F, Novelli G, et al: Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 2005; 37: 2535.
12. Schlitt HJ, Neipp M, Weimann A, et al: Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 1999; 17: 324
13. Freise CE, Ferrell L, Liu T, Ascher NL, Roberts JP: Effect of systemic cyclosporine on tumor recurrence after liver transplantation in a model of hepatocellular carcinoma. Transplantation 1999; 67: 510-513.
14. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, Suthanthiran M: Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530-534.
15. Nabel GJ: A transformed view of cyclosporine. Nature 1999; 397: 471-472.
16. Ferris JV, Baron RL, Marsh JW Jr, Oliver JH 3rd, Carr BI, Dodd GD 3rd: Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns. Radiology 1996; 198: 233-238.
17. Schumacher G, Oidtmann M, Rueggeberg A, Jacob D, Jonas S, Langrehr JM, Neuhaus R, Bahra M, Neuhaus P: Sirolimus inhibits growth of human hepatoma cells alone or combined with tacrolimus, while tacrolimus promotes cell growth. World J Gastroenterol 2005; 11: 1420-1425.
18. Mazzaferro V, Rondinara GF, Rossi G, et al: Milan multicenter experience in liver transplantation for hepatocellular carcinoma. Transplant Proc 1994; 26: 3557-3560.
19. Carr BI, Selby R, Madariaga J, et al: Prolonged survival after liver transplantation and cancer chemotherapy for advanced hepatocellular carcinoma. Transplant Proc 1993; 25: 1128-1129.
20. Stone MJ, Klintmalm GBG, Polter D, et al: Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients Gastroenterology 1993; 104: 196-202.
21. Cherqui D, Piedbois P, Pierga JY, et al: Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. Cancer 1994; 221: 2721-2726.
22. Roayaie S, Schwartz JD, Sung MW, Emre SH: Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis. Transplantation2004; 10: 534-540.